ReviR Therapeutics' RTX-117 receives FDA Rare Pediatric Disease Designation for Charcot-Marie-Tooth disease

Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic GEA eligible for ZIIHERA

Annovis Bio schedules corporate update webinar for next week

Cellenkos' CK0803 granted US FDA Fast Track designation for ALS

FDA approves Johnson & Johnson's IMAAVY (nipocalimab-aahu) to treat warm autoimmune haemolytic anaemia

Labcorp to offer FDA-cleared pTau-217 blood test for Alzheimer's assessment

Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product

European Commission grants orphan designation for Vanda's imsidolimab

United Therapeutics wins FDA acceptance for ralinepag PAH filing

Acadia wins EU approval for DAYBU as first treatment for Rett syndrome

Gilead expands Trodelvy role in first-line metastatic triple-negative breast cancer in Europe

GSK's Jemperli wins FDA priority review for advanced rectal cancer

European Commission grants orphan designation for Lundbeck's asedebart

Pulnovo Medical commences enrolment in PULSE-LHD IDE clinical trial

Nuvation Bio's safusidenib granted FDA Fast Track Designation for IDH1-mutant glioma treatment